Please use this identifier to cite or link to this item:
|Title:||Toulouse-Lautrec and medicine: A triumph over infirmity||Contributor(s):||Albury, William Randall (author); Weisz, George M (author)||Publication Date:||2013||Handle Link:||https://hdl.handle.net/1959.11/13812||Abstract:||Renowned 19th century French painter Henri de Toulouse-Lautrec's most obvious association with medicine is through his bone disease. The condition from which he probably suffered was first described in 1954 by the French physician Robert Weissman-Netter. It was named pycnodysostosis in 1962 by Marateaux and Lamy and was soon attributed to this artist as the 'Toulouse-Lautrec Syndrome.' The retrospective diagnosis of his skeletal condition is highly probable but cannot be definitive, as no autopsy was done when he died, no x-rays were taken of his bones during life, and there has been no subsequent exhumation of his remains to allow post-mortem studies to be carried out.||Publication Type:||Journal Article||Source of Publication:||Hektoen International, v.5 (3)||Publisher:||Hektoen Institute of Medicine||Place of Publication:||United States of America||ISSN:||2155-3017||Field of Research (FOR):||210307 European History (excl British, Classical Greek and Roman)||Socio-Economic Outcome Codes:||970121 Expanding Knowledge in History and Archaeology||Peer Reviewed:||Yes||HERDC Category Description:||C1 Refereed Article in a Scholarly Journal||Other Links:||http://www.hektoeninternational.org/Toulouse_Lautrec_and_medicine.html||Statistics to Oct 2018:||Visitors: 188
|Appears in Collections:||Journal Article|
Files in This Item:
checked on Mar 2, 2019
Items in Research UNE are protected by copyright, with all rights reserved, unless otherwise indicated.